Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.01 (+0.48%)
At close: Oct 21, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Other Non-Current Liabilities (2018 - 2019)

Updated

Black Diamond Therapeutics' Other Non-Current Liabilities came in at $16,000 for Q4 2019, down 99.6% from $4.02 million a year earlier.

Analysis

Black Diamond Therapeutics (BDTX) Other Non-Current Liabilities (2018 - 2019) Analysis & Trends

  • Going back by year, Other Non-Current Liabilities was $4.02 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Black Diamond Therapeutics 118.75 Mn -374.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 16,000.00
Dec 31, 2018 4.02 Mn
API Access

Black Diamond Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BDTX&period=max&api_key=YOUR_API_KEY